Lantern Pharma Inc. (LTRN) SEC Filings — 2025
11 SEC filings for Lantern Pharma Inc. (LTRN) in 2025.
Filings
- Lantern Pharma Files 8-K on Financials — 8-K · Nov 13, 2025
- Lantern Pharma Narrows Q3 Loss Amid R&D Cuts, Cash Up, Equity Down — 10-Q · Nov 12, 2025
- Lantern Pharma Inc. Files 8-K on Security Holder Vote — 8-K · Sep 23, 2025
- Lantern Pharma Narrows Q2 Loss, R&D Spend Down 22% — 10-Q · Aug 13, 2025
- Lantern Pharma Seeks OK for Director Slate, Stock Option Repricing — DEF 14A · Aug 8, 2025
- Lantern Pharma Inc. Files 8-K on Executive & Corporate Changes — 8-K · Jul 29, 2025
- Lantern Pharma Files 8-K — 8-K · Jul 3, 2025
- Lantern Pharma Files 10-Q for Q1 2025 — 10-Q · May 15, 2025
- Lantern Pharma Files 2024 Annual Report Amendment — 10-K/A · Apr 30, 2025
- Lantern Pharma Files 2024 10-K — 10-K · Mar 27, 2025
- Lantern Pharma Inc. Announces Board and Executive Compensation Changes — 8-K · Jan 10, 2025